Corvax still a long ways away... "Vaxil is advancing its CorVax™ preclinical program to validate effective immune response, including assessing convalescent patient plasma, in vitro cytotoxicity, in vivo immunogenicity and ex vivo T cell proliferation and cytokine release. We anticipate completing this work in the coming months and if successful, we will prepare for and commence our Phase 1 program once receiving approval to do so.
If we are successful in proving the safety of our COVID-19 Vaccine in Phase 1, we will continue the development of CorVax™ to Phase 2 and 3. Vaxil’s signal peptide platform is more easily and more efficiently scaled up"
Hopefully the world has a vaccine sooner than this! IF they ever get "approval" to even begin Phase 1 a few months from now...hoping for a breakthrough like most here but they have a better chance curing cancer IMO )